iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.81M
Expense Ratio	0.47%
PE Ratio	16.48
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.39%
Ex-Dividend Date	Dec 17, 2024
Payout Frequency	Annual
Payout Ratio	6.53%

Volume	53
Open	26.30
Previous Close	25.67
Day's Range	26.30 - 26.30
52-Week Low	17.86
52-Week High	28.74
Beta	0.71
Holdings	62
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

42.88% of assets

Name	Symbol	Weight
Supernus Pharmaceuticals, Inc.	SUPN	5.11%
argenx SE	ARGX	4.81%
SK Biopharmaceuticals Co., Ltd.	326030	4.41%
Xenon Pharmaceuticals Inc.	XENE	4.34%
PTC Therapeutics, Inc.	PTCT	4.33%
Neurocrine Biosciences, Inc.	NBIX	4.23%
Biogen Inc.	BIIB	4.13%
ACADIA Pharmaceuticals Inc.	ACAD	4.06%
H. Lundbeck AS Ordinary Shares - Class B	HLUNB.CO	3.73%
Denali Therapeutics Inc.	DNLI	3.72%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of 4.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 0.64%.